These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 582977)

  • 1. [Effect of a water-soluble derivative of silymarin on morphological and functional alterations of mouse hepatocytes induced by Frog Virus 3 (author's transl)].
    Gendrault JL; Steffan AM; Elharrar M; Kirn A
    Arzneimittelforschung; 1979; 29(5):786-91. PubMed ID: 582977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frog virus 3 induces a fatal hepatitis in rats.
    Gut JP; Anton M; Bingen A; Vetter JM; Kirn A
    Lab Invest; 1981 Sep; 45(3):218-28. PubMed ID: 6168820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A novel model of experimental toxic hepatitis/acute degenerative hepatitis induced by frog virus 3 (FV3) in the mouse (author's transl)].
    Elharrar M; Bingen A; Drillien R; Gendrault JL; Steffan AM; Kirn A
    Arzneimittelforschung; 1975 Oct; 25(10):1586-91. PubMed ID: 1081877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 6. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protection of mice with bacterial phospholipids against the lethal effect of Frog Virus 3 (FV 3) (author's transl)].
    Anton M; Kirn A
    Pathol Biol (Paris); 1979 May; 27(5):269-73. PubMed ID: 388298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of silymarin-N-methylglucamine salt and silybin-dihemisuccinate on (1-14C)-acetate incorporation in rat liver lipids (author's transl)].
    Schriewer H; Rauen HM
    Arzneimittelforschung; 1976 Feb; 26(2):235-8. PubMed ID: 947204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
    Bode JC; Schmidt U; Dürr HK
    Med Klin; 1977 Mar; 72(12):513-8. PubMed ID: 840125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.
    Lahiri-Chatterjee M; Katiyar SK; Mohan RR; Agarwal R
    Cancer Res; 1999 Feb; 59(3):622-32. PubMed ID: 9973210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
    Chrungoo VJ; Reen RK; Singh K; Singh J
    Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
    Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructural morphometric investigations on mouse liver after treatment with phalloidin and alpha-amanitin followed by application of silybin (author's transl)].
    Meiss R; Brauch F; Themann H
    Z Gastroenterol; 1981 Aug; 19(8):384-9. PubMed ID: 7281857
    [No Abstract]   [Full Text] [Related]  

  • 14. Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements.
    Shalan MG; Mostafa MS; Hassouna MM; El-Nabi SE; El-Refaie A
    Toxicology; 2005 Jan; 206(1):1-15. PubMed ID: 15590105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes.
    Ramellini G; Meldolesi J
    Arzneimittelforschung; 1976; 26(1):69-73. PubMed ID: 947182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of silybin action, IV. Structure-action relationship (author's transl)].
    Sonnenbichler J; Pohl A
    Hoppe Seylers Z Physiol Chem; 1980 Nov; 361(11):1757-61. PubMed ID: 6161072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative effect of silymarin on sawfly (Arge pullata)-induced hepatotoxicosis in sheep.
    Thamsborg SM; Jørgensen ; Brummerstedt E; Bjerregard J
    Vet Hum Toxicol; 1996 Apr; 38(2):89-91. PubMed ID: 8693692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O; Trcka V; Vakocová H; Tichý M
    Cas Lek Cesk; 1985 Feb; 124(6):165-9. PubMed ID: 3971403
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.